EUVIMEDEUVIMED entdecken
BeobachtungsstudieVergleichsstudieOpen Access · CC BY 4.0

Effectiveness of Indapamide Prolonged‐Release and Perindopril Versus Perindopril Monotherapy for Treated Uncontrolled Hypertension: A Target Trial Emulation

Céline Darricarrere iD, Virginie Simon iD, Manel Pladevall-Vila iD, Emmanuelle Jacquot, Morgane Ballon iD, Marie Mangin, Dominique Procureur, Jaume Aguado iD, Xabier Garcia-Albeniz iD

Pharmacoepidemiology and Drug Safety · 2026

DOI: 10.1002/pds.70295 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Pharmacoepidemiology and Drug Safety, 2026. Verfasst von Céline Darricarrere und 8 weiteren Autor:innen. Beteiligte Einrichtung: Servier, Suresnes, France. Hauptthemen laut MEDLINE: Perindopril, Indapamide, Antihypertensive Agents, Hypertension. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Servier.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To assess the effectiveness of indapamide prolonged release and perindopril in combination using blood pressure (BP) records collected in routine practice.

Methods

Using a target trial emulation framework, an observational retrospective cohort study was conducted. The data source was the United Kingdom's CPRD Aurum general practice database. Adults with systolic BP (SBP) ≥ 145 mmHg treated with perindopril 4/5 mg for ≥ 4 weeks at a stable dose who either added indapamide 1.5 mg to perindopril ( n = 193) or continued on perindopril monotherapy ( n = 14 571) were included. Balance between treatment arms was achieved with propensity score matching; results were explored in additional analyses using different eligibility criteria and alternative statistical methodologies. The primary outcome was change in SBP from baseline to Week 8 between indapamide added to perindopril versus perindopril monotherapy.

Results

In the primary analysis, indapamide added to perindopril yielded an additional SBP reduction of −6.3 mmHg (95% confidence interval [CI] −8.7 to −3.9) over perindopril monotherapy at Week 8. Results of additional analyses were consistent with the main analysis, but effect estimates varied due to diverse underlying assumptions.

Conclusions

Target trial emulation allowed assessment of antihypertensive treatment effectiveness, and indapamide plus perindopril yielded clinically meaningful decreases in SBP over perindopril monotherapy. Secondary and sensitivity analyses support that these findings were robust.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PerindoprilIndapamideAntihypertensive AgentsHypertensionHumansRetrospective StudiesDelayed-Action PreparationsBlood PressureFemaleMaleDrug Therapy, CombinationMiddle AgedTreatment OutcomeAgedUnited KingdomCohort Studies

Stichwörter der Autor:innen

antihypertensive treatment effectivenesscombination therapyreal‐world evidencetarget trial emulation

Substanzen

PerindoprilIndapamideAntihypertensive AgentsDelayed-Action Preparations

Autor:innen und Institutionen

  • Servier, Suresnes, France.
  • RTI Health Solutions, Barcelona, Spain.
  • The Center for Health Policy and Health Services Research, Henry Ford Health System, Detroit, Michigan, USA.
  • IT&M Stats, Neuilly-sur-Seine, France.
  • R&D Life Cycle Management, Suresnes, France.

ORCID-Profile: Céline Darricarrere, Virginie Simon, Manel Pladevall-Vila, Morgane Ballon, Jaume Aguado, Xabier Garcia-Albeniz

Förderung

  • Servier

Zitieren

APA

Darricarrere, C., Simon, V., Pladevall-Vila, M., Jacquot, E., Ballon, M., Mangin, M., Procureur, D., Aguado, J., & Garcia-Albeniz, X. (2026). Effectiveness of Indapamide Prolonged‐Release and Perindopril Versus Perindopril Monotherapy for Treated Uncontrolled Hypertension: A Target Trial Emulation. Pharmacoepidemiology and Drug Safety. https://doi.org/10.1002/pds.70295

Vancouver

Darricarrere C, Simon V, Pladevall-Vila M, Jacquot E, Ballon M, Mangin M, et al. Effectiveness of Indapamide Prolonged‐Release and Perindopril Versus Perindopril Monotherapy for Treated Uncontrolled Hypertension: A Target Trial Emulation. Pharmacoepidemiology and Drug Safety. 2026. doi:10.1002/pds.70295

BibTeX
@article{Darricarrere2026,
  author = {Darricarrere, Céline and Simon, Virginie and Pladevall-Vila, Manel and Jacquot, Emmanuelle and Ballon, Morgane and Mangin, Marie and Procureur, Dominique and Aguado, Jaume and Garcia-Albeniz, Xabier},
  title = {Effectiveness of Indapamide Prolonged‐Release and Perindopril Versus Perindopril Monotherapy for Treated Uncontrolled Hypertension: A Target Trial Emulation},
  journal = {Pharmacoepidemiology and Drug Safety},
  year = {2026},
  doi = {10.1002/pds.70295}
}
Kostenlos starten →